Nicolas Merigeau Healthcare News

This is selected healthcare news for Nicolas Merigeau, which is filed under People. There are 53 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/13/2022 MedinCell Signs a Licence Agreement With the Medicines Patent Pool to Fight Malaria Transmission, as Part of Its Global Health Mission | Business Wire
... medicinespatentpool.org MedinCell David Heuz√© Communication leader [email protected] +33 (0)6 83 25 21 86 NewCap Louis-Victor Delouvrier/Mathilde Bohin Investor Relations [email protected] +33 (0)1 44 71 94 94 NewCap Nicolas Merigeau Media Relations [email protected] +33 (0)1 44 71 94 94 ...
Business Wire
9/13/2022 MedinCell Signs a Licence Agreement With the Medicines Patent Pool to Fight Malaria Transmission, as Part of Its Global Health Mission
... https://www.businesswire.com/news/home/20220913006088/en/ CONTACT: MPP: David Heuzé Communication leader +33 (0)6 83 25 21 86NewCap Louis-Victor Delouvrier/Mathilde Bohin Investor Relations +33 (0)1 44 71 94 94NewCap Nicolas Merigeau Media Relations +33 (0)1 44 71 94 94 KEYWORD: EUROPE SWITZERLAND FRANCE INDUSTRY KEYWORD ...
Business Wire
9/13/2022 SPAC eureKING Obtains the TIBI label and Strengthens Its Status as a Prime Investor for the Creation of a Major Biomanufacturing Player in Europe
... eureKING is listed on the professional compartment of Euronext in Paris since May 12, 2022. View source version on businesswire.com: https://www.businesswire.com/news/home/20220913005842/en/ Contacts Presse : eureKING [email protected] Agence NewCap Nicolas Merigeau +33 (0)1 44 71 94 98 / [email protected] Arthur Rouill√© +33 (0)1 44 ...
Yahoo News
9/13/2022 MedinCell Signs a Licence Agreement With the Medicines Patent Pool to Fight Malaria Transmission, as Part of Its Global Health Mission
... medicinespatentpool.org MedinCell David Heuz√© Communication leader [email protected] +33 (0)6 83 25 21 86 NewCap Louis-Victor Delouvrier/Mathilde Bohin Investor Relations [email protected] +33 (0)1 44 71 94 94 NewCap Nicolas Merigeau Media Relations [email protected] +33 (0)1 44 71 94 94 ...
Yahoo News
9/13/2022 MedinCell Signs a Licence Agreement With the Medicines Patent Pool to Fight Malaria Transmission, as Part of Its Global Health Mission
... protected] MedinCell David Heuzé Communication leader [email protected] +33 (0)6 83 25 21 86 NewCap Louis-Victor Delouvrier/Mathilde Bohin Investor Relations [email protected] +33 (0)1 44 71 94 94 NewCap Nicolas Merigeau Media Relations [email protected] +33 (0)1 44 71 94 94 ...
pharmaceuticaldaily.com
9/6/2022 MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) Business Wire
9/5/2022 MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) | Business Wire Business Wire
9/5/2022 MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) | Business | The Daily News galvnews.com
8/29/2022 Phase 3 Study to Be Initiated for Second Long-acting Injectable Antipsychotic Using MedinCell's Technology metrolatinousa.com
1/31/2022 ABIONYX Pharma Announces Its Financial Agenda for the Year 2022 | Business Wire Business Wire
9/17/2020 Onxeo Reports its Financial Results for the First Half of 2020 and Provides an Update on its Activities Paris Stock Exchange:ONXEO.PA Globe Newswire
9/16/2020 ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update Nasdaq:ERYP Globe Newswire
9/14/2020 GeNeuro and the Karolinska Institutet’s Academic Specialist Center (ASC) Present Temelimab Neurodegeneration Prevention Study at MSVirtual2020 Business Wire
9/14/2020 ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment Nasdaq:ERYP Globe Newswire
7/29/2020 Transfer of the listing of Onxeo securities from the Euronext Paris regulated market (compartment C) to the Euronext Growth Paris multilateral trading facility Business Wire
7/7/2020 Implanet Announces H1 2020 Revenue Business Wire
7/1/2020 The University of Tours and Theradiag Sign Two Agreements Simultaneously: an Exclusive Licensing Agreement for the Production of COVID-19 Viral Proteins and a Global Collaboration Agreement That Could Lead to the Creation of Further Partnerships Business Wire
6/26/2020 ERYTECH Reports Voting Results from its Annual General Meeting Held on June 26, 2020 Nasdaq:ERYP
6/25/2020 ERYTECH extends its cash horizon by implementing a convertible bond financing Nasdaq:ERYP Globe Newswire
4/27/2020 GeNeuro: Financial Information and Business Update for the First Quarter 2020 Business Wire
4/22/2020 Theradiag Committed to Fight Covid-19 and Reviews the Potential Impact for 2020 Business Wire
4/20/2020 ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer Nasdaq:ERYP Globe Newswire
4/1/2020 IMPLANET AGM Of April 7, 2020 Business Wire
3/19/2020 Implanet: AGM Proceeding April 7, 2020 | Business Wire Business Wire
3/12/2020 ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update Business Insider